Literature DB >> 34301843

MicroRNA-10a Negatively Regulates CD4+ T Cell IL-10 Production through Suppression of Blimp1.

Wenjing Yang1, Liang Chen1,2, Leiqi Xu1, Anthony J Bilotta1, Suxia Yao1, Zhanju Liu2, Yingzi Cong3,4.   

Abstract

An uncontrolled CD4+ T cell response is a critical hallmark of autoimmune diseases. IL-10, which can be produced by both effector and regulatory CD4+ T cells, plays an essential role in the inhibition of autoimmunity. MicroRNAs are key molecules involved in regulating immune responses. However, how miR-10a regulates CD4+ T cell function in the pathogenesis of intestinal immune responses is not fully understood. In this study, we show that the mice with deficient miR-10a in CD4+ T cells were more resistant to intestinal inflammation upon inflammatory insult. miR-10a-deficient CD4+CD45Rbhi T cells were less colitogenic in Rag -/- mice, in which CD4+ T cell production of IL-10 was increased. miR-10a-deficient CD4+ T cells expressed a higher expression of IL-10 in vitro. Blocking the IL-10/IL-10R pathway in vivo aggravated colitis induced by miR-10a-deficient CD4+CD45Rbhi T cells. Mechanically, miR-10a suppressed CD4+ T cell production of IL-10 through targeting Prdm1, which encodes Blimp1. We further show that that CD4+ T cells lacking Blimp1 produced lower levels of IL-10 and induced more severe colitis in Rag -/- mice. These data thus establish the role of miR-10a in the inhibition of IL-10 production in CD4+ T cells to regulate intestinal homeostasis.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34301843      PMCID: PMC8323958          DOI: 10.4049/jimmunol.2100017

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  46 in total

1.  RORγt Represses IL-10 Production in Th17 Cells To Maintain Their Pathogenicity in Inducing Intestinal Inflammation.

Authors:  Mingming Sun; Chong He; Liang Chen; Wenjing Yang; Wei Wu; Feidi Chen; Anthony T Cao; Suxia Yao; Sara M Dann; T G Murali Dhar; Luisa Salter-Cid; Qihong Zhao; Zhanju Liu; Yingzi Cong
Journal:  J Immunol       Date:  2018-11-26       Impact factor: 5.422

2.  Transforming Growth Factor-β Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses.

Authors:  Joanne E Konkel; Dunfang Zhang; Peter Zanvit; Cheryl Chia; Tamsin Zangarle-Murray; Wenwen Jin; Songlin Wang; WanJun Chen
Journal:  Immunity       Date:  2017-04-18       Impact factor: 31.745

Review 3.  Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.

Authors:  Wei Wu; Feidi Chen; Zhanju Liu; Yingzi Cong
Journal:  Inflamm Bowel Dis       Date:  2016-06       Impact factor: 5.325

4.  Identification of microRNAs associated with ileal and colonic Crohn's disease.

Authors:  Feng Wu; Simin Zhang; Themistocles Dassopoulos; Mary L Harris; Theodore M Bayless; Stephen J Meltzer; Steven R Brant; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2010-10       Impact factor: 5.325

5.  Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.

Authors:  Magali Fasseu; Xavier Tréton; Cécile Guichard; Eric Pedruzzi; Dominique Cazals-Hatem; Christophe Richard; Thomas Aparicio; Fanny Daniel; Jean-Claude Soulé; Richard Moreau; Yoram Bouhnik; Marc Laburthe; André Groyer; Eric Ogier-Denis
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

Review 6.  MicroRNAs: how many in inflammatory bowel disease?

Authors:  Jeremy S Schaefer
Journal:  Curr Opin Gastroenterol       Date:  2016-07       Impact factor: 3.287

Review 7.  Innate and adaptive immunity in inflammatory bowel disease.

Authors:  Alessandra Geremia; Paolo Biancheri; Philip Allan; Gino R Corazza; Antonio Di Sabatino
Journal:  Autoimmun Rev       Date:  2013-06-15       Impact factor: 9.754

8.  IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis.

Authors:  Kai-Kai Chang; Li-Bing Liu; Li-Ping Jin; Bing Zhang; Jie Mei; Hui Li; Chun-Yan Wei; Wen-Jie Zhou; Xiao-Yong Zhu; Jun Shao; Da-Jin Li; Ming-Qing Li
Journal:  Cell Death Dis       Date:  2017-03-16       Impact factor: 8.469

9.  Murine Colitis modeling using Dextran Sulfate Sodium (DSS).

Authors:  Caitlyn G Whittem; Amanda D Williams; Christopher S Williams
Journal:  J Vis Exp       Date:  2010-01-19       Impact factor: 1.355

10.  MicroRNA-219a-5p suppresses intestinal inflammation through inhibiting Th1/Th17-mediated immune responses in inflammatory bowel disease.

Authors:  Yan Shi; Shenglan Dai; Caiyu Qiu; Tao Wang; Yong Zhou; Cuihua Xue; Jun Yao; Yaping Xu
Journal:  Mucosal Immunol       Date:  2019-10-18       Impact factor: 7.313

View more
  2 in total

Review 1.  Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.

Authors:  Patricia Teixeira Santana; Siane Lopes Bittencourt Rosas; Beatriz Elias Ribeiro; Ygor Marinho; Heitor S P de Souza
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

2.  miR-10c Facilitates White Spot Syndrome Virus Infection by Targeting Toll3 in Litopenaeus vannemei.

Authors:  Hongliang Zuo; Xinxin Liu; Mengting Luo; Linwei Yang; Zhiming Zhu; Shaoping Weng; Jianguo He; Xiaopeng Xu
Journal:  Front Immunol       Date:  2021-12-07       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.